BioLineRx closes $3.75 million offering, adds warrant coverage from existing investorAug 31FinancingBioLineRx, Ltd.
Roche results post for two terminated Morpheus umbrella trials; new Phase 1/2 studies registeredAug 7Weekly roundup, 6 itemsatezolizumabBioLineRx, Ltd.
Sign in